1. Home
  2. LICN vs DYAI Comparison

LICN vs DYAI Comparison

Compare LICN & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lichen China Limited

LICN

Lichen China Limited

N/A

Current Price

$1.11

Market Cap

17.1M

Sector

N/A

ML Signal

N/A

Logo Dyadic International Inc.

DYAI

Dyadic International Inc.

HOLD

Current Price

$0.42

Market Cap

17.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LICN
DYAI
Founded
2004
1979
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.1M
17.0M
IPO Year
2021
2026

Fundamental Metrics

Financial Performance
Metric
LICN
DYAI
Price
$1.11
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
17.1K
192.2K
Earning Date
04-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,090,345.00
Revenue This Year
N/A
$122.79
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.34
52 Week High
$9.49
$1.60

Technical Indicators

Market Signals
Indicator
LICN
DYAI
Relative Strength Index (RSI) 44.41 25.71
Support Level $1.03 N/A
Resistance Level $1.40 $0.90
Average True Range (ATR) 0.09 0.07
MACD -0.00 0.00
Stochastic Oscillator 59.52 30.35

Price Performance

Historical Comparison
LICN
DYAI

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational, and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and the sales of financial and taxation training software.

About DYAI Dyadic International Inc.

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: